Table 2 Proportion of users performing culture and susceptibility testing in different clinical scenarios
Scenarios | Number of users (%) n = 63 |
|---|---|
When I treat pyoderma (any type) with systemic antibiotics | 12 (19) |
When I treat UTI (any type) with antibiotics | 25 (39) |
When I treat recurrent pyoderma with systemic antibiotics | 53 (84) |
When I treat recurrent UTI with antibiotics | 50 (79) |
When I treat rare infections | 35 (55) |
When empiric treatment fails | 43 (68) |
I rarely perform C&S | 1 (2) |
Other | 6 (10) |